Arrowhead Pharmaceuticals’ Lincense Collaboration Agreement with Sarepta Therapeutics

Leila Ahmed North America Legal Chronicle
Tagged:

Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics.Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global licensing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here